257 related articles for article (PubMed ID: 26993043)
1. The FGF21-adiponectin axis in controlling energy and vascular homeostasis.
Hui X; Feng T; Liu Q; Gao Y; Xu A
J Mol Cell Biol; 2016 Apr; 8(2):110-9. PubMed ID: 26993043
[TBL] [Abstract][Full Text] [Related]
2. Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice.
Lin Z; Tian H; Lam KS; Lin S; Hoo RC; Konishi M; Itoh N; Wang Y; Bornstein SR; Xu A; Li X
Cell Metab; 2013 May; 17(5):779-89. PubMed ID: 23663741
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor 21 prevents atherosclerosis by suppression of hepatic sterol regulatory element-binding protein-2 and induction of adiponectin in mice.
Lin Z; Pan X; Wu F; Ye D; Zhang Y; Wang Y; Jin L; Lian Q; Huang Y; Ding H; Triggle C; Wang K; Li X; Xu A
Circulation; 2015 May; 131(21):1861-71. PubMed ID: 25794851
[TBL] [Abstract][Full Text] [Related]
4. FGF21 Regulates Metabolism Through Adipose-Dependent and -Independent Mechanisms.
BonDurant LD; Ameka M; Naber MC; Markan KR; Idiga SO; Acevedo MR; Walsh SA; Ornitz DM; Potthoff MJ
Cell Metab; 2017 Apr; 25(4):935-944.e4. PubMed ID: 28380381
[TBL] [Abstract][Full Text] [Related]
5. FGF21-FGFR1 Coordinates Phospholipid Homeostasis, Lipid Droplet Function, and ER Stress in Obesity.
Ye M; Lu W; Wang X; Wang C; Abbruzzese JL; Liang G; Li X; Luo Y
Endocrinology; 2016 Dec; 157(12):4754-4769. PubMed ID: 27690692
[TBL] [Abstract][Full Text] [Related]
6. Liver-adipose tissue crosstalk: A key player in the pathogenesis of glucolipid metabolic disease.
Ye DW; Rong XL; Xu AM; Guo J
Chin J Integr Med; 2017 Jun; 23(6):410-414. PubMed ID: 28795382
[TBL] [Abstract][Full Text] [Related]
7. An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice.
Holland WL; Adams AC; Brozinick JT; Bui HH; Miyauchi Y; Kusminski CM; Bauer SM; Wade M; Singhal E; Cheng CC; Volk K; Kuo MS; Gordillo R; Kharitonenkov A; Scherer PE
Cell Metab; 2013 May; 17(5):790-7. PubMed ID: 23663742
[TBL] [Abstract][Full Text] [Related]
8. FGF21 activates AMPK signaling: impact on metabolic regulation and the aging process.
Salminen A; Kauppinen A; Kaarniranta K
J Mol Med (Berl); 2017 Feb; 95(2):123-131. PubMed ID: 27678528
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast Growth Factor 21 Protects against Atherosclerosis via Fine-Tuning the Multiorgan Crosstalk.
Jin L; Lin Z; Xu A
Diabetes Metab J; 2016 Feb; 40(1):22-31. PubMed ID: 26912152
[TBL] [Abstract][Full Text] [Related]
10. Central Resistin/TLR4 Impairs Adiponectin Signaling, Contributing to Insulin and FGF21 Resistance.
Benomar Y; Amine H; Crépin D; Al Rifai S; Riffault L; Gertler A; Taouis M
Diabetes; 2016 Apr; 65(4):913-26. PubMed ID: 26740596
[TBL] [Abstract][Full Text] [Related]
11. Perilipin 5 Deletion Unmasks an Endoplasmic Reticulum Stress-Fibroblast Growth Factor 21 Axis in Skeletal Muscle.
Montgomery MK; Mokhtar R; Bayliss J; Parkington HC; Suturin VM; Bruce CR; Watt MJ
Diabetes; 2018 Apr; 67(4):594-606. PubMed ID: 29378767
[TBL] [Abstract][Full Text] [Related]
12. FGF21-receptor agonists: an emerging therapeutic class for obesity-related diseases.
Sonoda J; Chen MZ; Baruch A
Horm Mol Biol Clin Investig; 2017 May; 30(2):. PubMed ID: 28525362
[TBL] [Abstract][Full Text] [Related]
13. Cross-talk between adipose tissue and vasculature: role of adiponectin.
Li FY; Cheng KK; Lam KS; Vanhoutte PM; Xu A
Acta Physiol (Oxf); 2011 Sep; 203(1):167-80. PubMed ID: 21062420
[TBL] [Abstract][Full Text] [Related]
14. Lack of overt FGF21 resistance in two mouse models of obesity and insulin resistance.
Hale C; Chen MM; Stanislaus S; Chinookoswong N; Hager T; Wang M; Véniant MM; Xu J
Endocrinology; 2012 Jan; 153(1):69-80. PubMed ID: 22067317
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice.
Xu J; Lloyd DJ; Hale C; Stanislaus S; Chen M; Sivits G; Vonderfecht S; Hecht R; Li YS; Lindberg RA; Chen JL; Jung DY; Zhang Z; Ko HJ; Kim JK; Véniant MM
Diabetes; 2009 Jan; 58(1):250-9. PubMed ID: 18840786
[TBL] [Abstract][Full Text] [Related]
16. Regulation of longevity by FGF21: Interaction between energy metabolism and stress responses.
Salminen A; Kaarniranta K; Kauppinen A
Ageing Res Rev; 2017 Aug; 37():79-93. PubMed ID: 28552719
[TBL] [Abstract][Full Text] [Related]
17. Impact of FGF21 on glycemic control.
Strowski MZ
Horm Mol Biol Clin Investig; 2017 Jun; 30(2):. PubMed ID: 28593912
[TBL] [Abstract][Full Text] [Related]
18. FGF21 is not required for glucose homeostasis, ketosis or tumour suppression associated with ketogenic diets in mice.
Stemmer K; Zani F; Habegger KM; Neff C; Kotzbeck P; Bauer M; Yalamanchilli S; Azad A; Lehti M; Martins PJ; Müller TD; Pfluger PT; Seeley RJ
Diabetologia; 2015 Oct; 58(10):2414-23. PubMed ID: 26099854
[TBL] [Abstract][Full Text] [Related]
19. Physiology and Endocrinology Symposium: FGF21: Insights into mechanism of action from preclinical studies.
Antonellis PJ; Kharitonenkov A; Adams AC
J Anim Sci; 2014 Feb; 92(2):407-13. PubMed ID: 24398833
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast growth factor 21 improves insulin resistance and ameliorates renal injury in db/db mice.
Kim HW; Lee JE; Cha JJ; Hyun YY; Kim JE; Lee MH; Song HK; Nam DH; Han JY; Han SY; Han KH; Kang YS; Cha DR
Endocrinology; 2013 Sep; 154(9):3366-76. PubMed ID: 23825123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
